MM&M presents its fifth annual compilation of the Top 40 Healthcare Transformers. This year’s class includes individuals from the widest range of organizations yet – everyone from Pfizer and GlaxoSmithKline to The New York Times and the North Carolina Department of Health and Human Services.
MM&M’s Transforming Healthcare coverage includes:
Profiles of each of the Top 40 honorees, including deeper dives on several of the list’s most groundbreaking individuals
MM&M’s third annual list of Top 10 Innovation Catalysts, the agency-, vendor-, and publisher-based execs who have prodded Big Pharma and the startup community towards health-tech nirvana.
An infographic detailing all things T40 past and present, including geographic location, background, area of expertise, and more.
Five Years On: Members of the inaugural class of MM&M’s Healthcare Transformers reflect on what they’ve learned about health, technology, and the intersection thereof during the last five years.
Patient-centricity comes to clinical trials
More sites. More at-home data collection. More opportunities to be heard. It took longer than anyone hoped, but the clinical-trial world has finally embraced the tactics and technologies likely to spur greater participation and trim overwhelming costs. But have patients noticed? MM&M shares examples of programs that have produced results.